- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.07. | AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline | ||
| 01.07. | Piramal Pharma announces $90m investment to expand US sites | ||
| 30.06. | WHO accuses China of withholding Covid-19 genetic data | ||
| 30.06. | US trade tariffs and the potential impact on pharma supply chains | ||
| 30.06. | Vetter breaks ground on $285m US clinical manufacturing site | ||
| 30.06. | CKD anemia market expected to reach $5.3bn across the 7MM by 2034 | ||
| 30.06. | FDA removes safety programme for CAR-T therapies to boost uptake | ||
| 30.06. | Sobi gains FDA approval for Gamifant to treat HLH/MAS | ||
| 30.06. | Torrent Pharmaceuticals to acquire stake in JB Pharma for $3bn | ||
| 27.06. | FDA approves label updates for BMS' CAR T cell therapies | ||
| 27.06. | AI in drug discovery: from hypothetical to reality | ||
| 27.06. | Viatris gains China approval for Yupelri to treat COPD | ||
| 27.06. | Novo Nordisk teams up with WeightWatchers in latest telehealth push | ||
| 27.06. | Why can't the US figure out weight loss drug prices? | ||
| 27.06. | Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies | ||
| 26.06. | BioCity's SC0062 gains NMPA breakthrough therapy designation | ||
| 26.06. | Innovation in Focus: Highlights from the Two-Day London Biotechnology Show 2025 | ||
| 26.06. | UK steps up with £1.25bn Gavi vaccine pledge as US funding disappears | ||
| 26.06. | Eli Lilly receives FDA approval for Amyvid label update | ||
| 26.06. | How AI and machine learning are transforming drug discovery | ||
| 26.06. | Novartis concludes Regulus Therapeutics acquisition | ||
| 25.06. | Gilead eyes Kymera's 'adhesive' cancer drug in $750m deal | ||
| 25.06. | Navigating uncertainty: the future of vaccine oversight amid CDC firings | ||
| 25.06. | How will RFK Jr's American dream for vaccines play out? | ||
| 25.06. | EHDS regulation will depend on strong patient confidence |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .